Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michael J. Sax"'
Publikováno v:
Journal of Drug Assessment
Background: Specialty medicines continue to increase as a percentage of spending with biologics representing a large portion of specialty spending. Health plans expect to adjust their formularies to maximize expected savings from biosimilars. Objecti
Publikováno v:
Journal of Drug Assessment
Background: Cancer care is shifting from chemotherapy to more effective targeted immunotherapies. New therapies, some existing therapies with expanded indications (including maintenance) and many therapies with price increases require re-evaluation.
Publikováno v:
Journal of Managed Care Pharmacy. 11:1-28
Autor:
Michael J. Sax
Publikováno v:
Journal of Managed Care Pharmacy. 5:289-295
Publikováno v:
Drug Information Journal. 30:609-619
The United States spends more of its gross domestic product on health care than any other industrialized nation. The benefits of this expenditure, however, are not directly recognized in improved h...
Autor:
Michael J. Sax, Amal Jubran, Diana J. Kaniecki, Nicholas J. Gross, Karl Schuttenhelm, Joe W. Ramsdell, Frank A. Sonnenberg, Raffi I. Simonian, Renée J. Goldberg Arnold
Publikováno v:
Chest. 103:678-684
The charts of 311 patients receiving theophylline (T) and 289 patients receiving ipratropium bromide (IB) for COPD were reviewed to determine the total costs and cost-effectiveness of these 2 agents in 3 different health-care settings. A direct cost-
Autor:
Michael J, Sax
Publikováno v:
Journal of managed care pharmacy : JMCP. 11(1 Suppl)
Autor:
Michael J. Sax
Publikováno v:
Journal of Managed Care Pharmacy. 11:S3-S4
Copyright© 2005, Academy of Managed Care Pharmacy. All rights reserved. Author Efforts to provide optimal care while controlling overall costs have led multiple health care disciplines to invest in outcomes evaluation and monitoring. The comparison
Publikováno v:
American Journal of Health-System Pharmacy. 42:304-308
The effectiveness of a pharmacist-managed warfarin anticoagulation clinic in maintaining therapeutic prothrombin times and preventing hospitalizations secondary to inadequate control of anticoagulation was evaluated. Patients who had received warfari
Autor:
Michael J. Sax
Publikováno v:
Pharmacotherapy. 7(6 Pt 2)
The H2-receptor antagonists cimetidine, ranitidine, and famotidine are well tolerated, with a low frequency and similar spectrum of adverse effects. The occasional problematic effects that have been associated with these agents include central nervou